Tyra Biosciences Inc (TYRA) Actualités

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences to Present at Upcoming Investor Conferences PR Newswire CARLSBAD, Calif., Feb. 11, 2025...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors

Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors PR Newswire CARLSBAD, Calif., Jan...

Form 144 - Report of proposed sale of securities

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium

Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium PR...

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle...

Form 144 - Report of proposed sale of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 144 - Report of proposed sale of securities